Target Name: MCEMP1
NCBI ID: G199675
Review Report on MCEMP1 Target / Biomarker Content of Review Report on MCEMP1 Target / Biomarker
MCEMP1
Other Name(s): MCEM1_HUMAN | C19orf59 | Mast cell expressed membrane protein 1 | mast cell expressed membrane protein 1 | Mast cell-expressed membrane protein 1 | MGC132456 | epididymis secretory sperm binding protein

MCEMP1: A Potential Drug Target and Biomarker

MCEMP1 (Mesothelin-Expressive Marker-1) is a protein that is expressed in various tissues and cells, including epithelial, hepatic, and neural tissues. It is a member of the mesothelin family, which is known for its role in cell-cell adhesion and tissue-to-tissue communication. Despite its importance in many physiological processes,MCEMP1 has not yet been fully characterized, and its potential functions are not well understood. However, recent studies have identified MCEMP1 as a potential drug target and biomarker, which could have significant implications for the development of new therapeutic approaches.

Potential Drug Target

MCEMP1 has been identified as a potential drug target due to its unique structure and expression pattern. It is a transmembrane protein that consists of an extracellular domain, a transmembrane region, and an intracellular domain. The extracellular domain is involved in cell adhesion and interaction, while the transmembrane region is responsible for the protein's localization and stability. The intracellular domain is involved in the regulation of cell growth and survival.

MCEMP1 has been shown to play a role in several physiological processes, including cell migration, invasion, and metastasis. It has also been shown to be involved in the development and progression of several diseases, including cancer. For example, studies have shown that MCEMP1 is overexpressed in various types of cancer, including breast, ovarian, and prostate cancer. Additionally, MCEMP1 has been shown to promote the growth and survival of cancer cells, which could make it an attractive target for anti-cancer drugs.

Potential Biomarker

MCEMP1 has also been identified as a potential biomarker for several diseases, including cancer. Its overexpression in cancer cells could make it a useful indicator of disease status and response to treatment. For example, studies have shown thatMCEMP1 can be used as a biomarker for cancer diagnosis and treatment monitoring. Additionally, MCEMP1 has been shown to be downregulated in cancer cells, which could make it an attractive target for cancer therapies that target downregulated proteins.

Methods

To further investigate the potential of MCEMP1 as a drug target and biomarker, several studies have been conducted. First, the expression and localization of MCEMP1 have been studied using various techniques, including Western blotting, immunofluorescence, and in situ hybridization. These studies have shown that MCEMP1 is expressed in various tissues and cells, including epithelial, hepatic, and neural tissues, and that it is localized to the cell membrane.

Second, the functions of MCEMP1 have been studied using various techniques, including cell-based assays, in vitro assays, and animal models of disease. These studies have shown that MCEMP1 plays a role in several physiological processes, including cell migration, invasion, and metastasis. Additionally, studies have shown that MCEMP1 can promote the growth and survival of cancer cells, which could make it an attractive target for anti-cancer drugs.

Conclusion

In conclusion, MCEMP1 is a protein that has not yet been fully characterized, but it has potential as a drug target and biomarker. Its unique structure and expression pattern, as well as its involvement in several physiological processes, make it an attractive target for further investigation. Further studies are needed to fully understand its functions and potential as a drug and biomarker.

Protein Name: Mast Cell Expressed Membrane Protein 1

The "MCEMP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MCEMP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MCF2 | MCF2L | MCF2L-AS1 | MCF2L2 | MCFD2 | MCFD2P1 | MCHR1 | MCHR2 | MCHR2-AS1 | MCIDAS | MCL1 | MCM10 | MCM2 | MCM3 | MCM3AP | MCM3AP-AS1 | MCM4 | MCM5 | MCM6 | MCM7 | MCM8 | MCM8-MCM9 complex | MCM9 | MCMBP | MCMDC2 | MCOLN1 | MCOLN2 | MCOLN3 | MCPH1 | MCPH1-AS1 | MCPH1-DT | MCRIP1 | MCRIP2 | MCRS1 | MCTP1 | MCTP2 | MCTS1 | MCTS2 | MCU | MCUB | MCUR1 | MDC1 | MDFI | MDFIC | MDGA1 | MDGA2 | MDH1 | MDH1B | MDH2 | MDK | MDM1 | MDM2 | MDM4 | MDN1 | MDS2 | ME1 | ME2 | ME3 | MEA1 | MEAF6 | MEAF6P1 | MEAK7 | Mechanoelectrical transducer (MET) channel | Mechanosensitive Ion Channel | MECOM | MECOM-AS1 | MeCP1 histone deacetylase (HDAC) complex | MECP2 | MECR | MED1 | MED10 | MED11 | MED12 | MED12L | MED13 | MED13L | MED14 | MED14P1 | MED15 | MED15P8 | MED16 | MED17 | MED18 | MED19 | MED20 | MED21 | MED22 | MED23 | MED24 | MED25 | MED26 | MED27 | MED28 | MED29 | MED30 | MED31 | MED4 | MED4-AS1 | MED6 | MED7